Analyst Viewpoint
Growth in prevalence of skin infections and increase in surgical site infections are key factors boosting the global topical antibiotics market size. Almost 40% of the global population is affected by skin infections.
Topical antibiotics help in the treatment of these disorders. If not treated on time, skin-related ailments can also affect the intestinal flora. Surgical site infections are usually observed post surgeries. Topical antibiotics prevent the proliferation of bacteria at the site of surgery, thereby rendering it safe and uncontaminated.
Manufacturers of topical antibiotics are engaged in formulating ointments and solutions that are efficient enough to combat antimicrobial resistance. This is creating lucrative topical antibiotics industry opportunities for companies operating in the industry.
Key players in the global topical antibiotics market are launching novel skin-specific antibiotics and cutaneous antibacterial solutions to strengthen their global position.
Topical antibiotics are a class of antibiotics that hamper bacterial cell wall growth. Several external infections can be chronic in nature, thereby resulting in skin irritation.
Topical antibiotics play an important role in treating secondary bacterial infections of skin disorders such as leg ulcers and eczema. Development of novel antibacterial ointments and solutions that target bacteria that is resistant to various drugs is one of the key topical antibiotics market trends.
Currently, drug developers are working on addressing several issues pertaining to the usage of topical antibiotics such as local hypersensitivity and bacterial resistance.
Antibacterial ointments account for more than 40% of topical antibiotics market share. They contain petrolatum, which is a good occlusive agent and functions as lubricant and emollient (as water is a vital epidermal plasticizer).
As per the WHO, more than 900 million people across the globe are afflicted with skin infections such as acne, bacterial dermatitis, cellulitis, and impetigo affect. Infectious diseases are one of the prominent causes of death in developing countries.
Certain comorbid conditions also increase susceptibility to bacterial skin infections. These conditions include vascular insufficiency, diabetes, and being immunocompromised, especially chemotherapy patients suffering from neutropenia.
Incidence of bacterial skin infections has been rising across the globe owing to several factors such as changes in lifestyle, poor hygiene practices, especially in underdeveloped countries, and growth in consumption of junk food. Thus, high prevalence of skin diseases is driving the demand for topical antibiotics for bacterial skin conditions.
Surgical site infection (SSI) is among the leading causes of hospital acquired infections worldwide. These infections are generally observed post surgeries. More than 40,000 patients are identified with these infections as of now in the U.S. alone.
Topical antibiotics, also known as topical microbial agents, eliminate/prevent bacterial contamination on being applied at surgical sites, as their concentration supersedes minimum inhibitory concentration (MIC).
The ongoing trend is that of using topical antibiotics for prophylaxis in ophthalmic surgical procedures. In July 2022, bioMérieux, Evotec SE, and Boehringer Ingelheim announced that they had entered into a joint venture for creating the next generation of topical antibiotics for fighting antimicrobial resistance developed by certain patients.
The CDC is also opting for funding activities through its Antimicrobial Resistance initiative that supports more than 50 state health departments and various local health departments. It has tied up with the private sector as well. This initiative is contributing to the growth of the topical antibiotics market.
North America accounted for the largest share of the global topical antibiotics landscape in 2022. The region is likely to maintain its dominant position during the forecast period.
Burns and fires are the fifth leading cause of injury-related fatalities in children aged between 1 and 19 in the U.S. Presence of well-established infrastructure for healthcare is also one of the primary factors driving market progress in North America.
Asia Pacific is also projected to record substantial market development in the near future. Vast population base, and poor sanitation and hygiene practices, especially in the densely populated countries such as India and China, are likely to boost the topical antibiotics market demand in the region.
On the other hand, the topical antibiotics market forecast in Europe appears promising owing to the increase in number of surgeries, which are giving rise to surgical site-related infections. Growth in incidence of impetigo infection that needs medications such as clindamycin and mupirocin is also likely to bolster market statistics in the region in the near future.
The global topical antibiotics sector is fragmented, with the presence of several leading players. Companies in the topical antibiotics landscape are engaged in research and development activities to introduce novel topical antibiotics for bacterial skin conditions at regular intervals. They are also striving to improve the clinical efficacy of medications.
Novartis AG, GlaxoSmithKline Plc, Perrigo Company Plc, Pfizer, Inc., Almirall, S.A., Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.), Medimetriks Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., and Mayne Pharma Group Limited are some of the leading players operating in the global market.
The topical antibiotics market report summarizes these companies based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 6.5 Bn |
| Market Forecast (Value) in 2031 | US$ 10.0 Bn |
| Growth Rate (CAGR) | 5.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 6.5 Bn in 2022
It is projected to grow at a CAGR of 5.1% from 2023 to 2031
Growth in prevalence of skin infections and increase in occurrence of surgical site infections
The retail pharmacies segment accounted for the largest share in 2022
North America was the dominant region in 2022
Novartis AG, GlaxoSmithKline Plc, Perrigo Company Plc, Pfizer, Inc., Almirall, S.A., Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.), Medimetriks Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., and Mayne Pharma Group Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Topical Antibiotics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Topical Antibiotics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Topical Antibiotics Market Analysis and Forecast, by Drug Class
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Class, 2017–2031
6.3.1. Tetracycline
6.3.2. Amino-glycosides
6.3.3. Erythromycin
6.3.4. Clindamycin
6.3.5. Others
6.4. Market Attractiveness, by Drug Class
7. Global Topical Antibiotics Market Analysis and Forecast, by Dosage Form
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Dosage Form, 2017–2031
7.3.1. Ointments
7.3.2. Creams
7.3.3. Powders
7.3.4. Gels
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Dosage Form
8. Global Topical Antibiotics Market Analysis and Forecast, By Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Indication, 2017–2031
8.3.1. Skin Infection
8.3.2. Eye Infection
8.3.3. Bromhidrosis
8.3.4. Others
8.4. Market Attractiveness, By Indication
9. Global Topical Antibiotics Market Analysis and Forecast, by Product Type
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Product Type, 2017–2031
9.3.1. Prescription
9.3.2. OTC
9.4. Market Attractiveness, by Product Type
10. Global Topical Antibiotics Market Analysis and Forecast, by Distribution Channel
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2017–2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Others
10.4. Market Attractiveness, by Distribution Channel
11. Global Topical Antibiotics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Topical Antibiotics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Drug Class, 2017–2031
12.2.1. Tetracycline
12.2.2. Amino-glycosides
12.2.3. Erythromycin
12.2.4. Clindamycin
12.2.5. Others
12.3. Market Attractiveness, by Drug Class
12.4. Market Value Forecast, by Dosage Form, 2017–2031
12.4.1. Ointments
12.4.2. Creams
12.4.3. Powders
12.4.4. Gels
12.4.5. Others
12.5. Market Attractiveness, by Dosage Form
12.6. Market Value Forecast, By Indication, 2017–2031
12.6.1. Skin Infection
12.6.2. Eye Infection
12.6.3. Bromhidrosis
12.6.4. Others
12.7. Market Attractiveness, By Indication
12.8. Market Value Forecast, by Product Type, 2017–2031
12.8.1. Prescription
12.8.2. OTC
12.9. Market Attractiveness, by Product Type
12.10. Market Value Forecast, by Distribution Channel, 2017–2031
12.10.1. Hospital Pharmacies
12.10.2. Retail Pharmacies
12.10.3. Others
12.11. Market Attractiveness, by Distribution Channel
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Drug Class
12.13.2. By Dosage Form
12.13.3. By Indication
12.13.4. By Product Type
12.13.5. By Distribution Channel
12.13.6. By Country
13. Europe Topical Antibiotics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Drug Class, 2017–2031
13.2.1. Tetracycline
13.2.2. Amino-glycosides
13.2.3. Erythromycin
13.2.4. Clindamycin
13.2.5. Others
13.3. Market Attractiveness, by Drug Class
13.4. Market Value Forecast, by Dosage Form, 2017–2031
13.4.1. Ointments
13.4.2. Creams
13.4.3. Powders
13.4.4. Gels
13.4.5. Others
13.5. Market Attractiveness, by Dosage Form
13.6. Market Value Forecast, By Indication, 2017–2031
13.6.1. Skin Infection
13.6.2. Eye Infection
13.6.3. Bromhidrosis
13.6.4. Others
13.7. Market Attractiveness, By Indication
13.8. Market Value Forecast, by Product Type, 2017–2031
13.8.1. Prescription
13.8.2. OTC
13.9. Market Attractiveness, by Product Type
13.10. Market Value Forecast, by Distribution Channel, 2017–2031
13.10.1. Hospital Pharmacies
13.10.2. Retail Pharmacies
13.10.3. Others
13.11. Market Attractiveness, by Distribution Channel
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Drug Class
13.13.2. By Dosage Form
13.13.3. By Indication
13.13.4. By Product Type
13.13.5. By Distribution Channel
13.13.6. By Country/Sub-region
14. Asia Pacific Topical Antibiotics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Drug Class, 2017–2031
14.2.1. Tetracycline
14.2.2. Amino-glycosides
14.2.3. Erythromycin
14.2.4. Clindamycin
14.2.5. Others
14.3. Market Attractiveness, by Drug Class
14.4. Market Value Forecast, by Dosage Form, 2017–2031
14.4.1. Ointments
14.4.2. Creams
14.4.3. Powders
14.4.4. Gels
14.4.5. Others
14.5. Market Attractiveness, by Dosage Form
14.6. Market Value Forecast, By Indication, 2017–2031
14.6.1. Skin Infection
14.6.2. Eye Infection
14.6.3. Bromhidrosis
14.6.4. Others
14.7. Market Attractiveness, By Indication
14.8. Market Value Forecast, by Product Type, 2017–2031
14.8.1. Prescription
14.8.2. OTC
14.9. Market Attractiveness, by Product Type
14.10. Market Value Forecast, by Distribution Channel, 2017–2031
14.10.1. Hospital Pharmacies
14.10.2. Retail Pharmacies
14.10.3. Others
14.11. Market Attractiveness, by Distribution Channel
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Drug Class
14.13.2. By Dosage Form
14.13.3. By Indication
14.13.4. By Product Type
14.13.5. By Distribution Channel
14.13.6. By Country/Sub-region
15. Latin America Topical Antibiotics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Drug Class, 2017–2031
15.2.1. Tetracycline
15.2.2. Amino-glycosides
15.2.3. Erythromycin
15.2.4. Clindamycin
15.2.5. Others
15.3. Market Attractiveness, by Drug Class
15.4. Market Value Forecast, by Dosage Form, 2017–2031
15.4.1. Ointments
15.4.2. Creams
15.4.3. Powders
15.4.4. Gels
15.4.5. Others
15.5. Market Attractiveness, by Dosage Form
15.6. Market Value Forecast, By Indication, 2017–2031
15.6.1. Skin Infection
15.6.2. Eye Infection
15.6.3. Bromhidrosis
15.6.4. Others
15.7. Market Attractiveness, By Indication
15.8. Market Value Forecast, by Product Type, 2017–2031
15.8.1. Prescription
15.8.2. OTC
15.9. Market Attractiveness, by Product Type
15.10. Market Value Forecast, by Distribution Channel, 2017–2031
15.10.1. Hospital Pharmacies
15.10.2. Retail Pharmacies
15.10.3. Others
15.11. Market Attractiveness, by Distribution Channel
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Drug Class
15.13.2. By Dosage Form
15.13.3. By Indication
15.13.4. By Product Type
15.13.5. By Distribution Channel
15.13.6. By Country/Sub-region
16. Middle East & Africa Topical Antibiotics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Drug Class, 2017–2031
16.2.1. Tetracycline
16.2.2. Amino-glycosides
16.2.3. Erythromycin
16.2.4. Clindamycin
16.2.5. Others
16.3. Market Attractiveness, by Drug Class
16.4. Market Value Forecast, by Dosage Form, 2017–2031
16.4.1. Ointments
16.4.2. Creams
16.4.3. Powders
16.4.4. Gels
16.4.5. Others
16.5. Market Attractiveness, by Dosage Form
16.6. Market Value Forecast, By Indication, 2017–2031
16.6.1. Skin Infection
16.6.2. Eye Infection
16.6.3. Bromhidrosis
16.6.4. Others
16.7. Market Attractiveness, By Indication
16.8. Market Value Forecast, by Product Type, 2017–2031
16.8.1. Prescription
16.8.2. OTC
16.9. Market Attractiveness, by Product Type
16.10. Market Value Forecast, by Distribution Channel, 2017–2031
16.10.1. Hospital Pharmacies
16.10.2. Retail Pharmacies
16.10.3. Others
16.11. Market Attractiveness, by Distribution Channel
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Drug Class
16.13.2. By Dosage Form
16.13.3. By Indication
16.13.4. By Product Type
16.13.5. By Distribution Channel
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Novartis AG
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. GlaxoSmithKline plc
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Perrigo Company plc
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Pfizer, Inc.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Almirall, SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Medimetriks Pharmaceuticals, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Taro Pharmaceutical Industries Ltd.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Mayne Pharma Group Ltd.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
List of Tables
Table 01: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 02: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 03: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 04: Global Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 05: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 06: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 09: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 10: North America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 11: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 12: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 15: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 16: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 17: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 19: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 21: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 22: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 23: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 24: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 25: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 27: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 28: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 29: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 30: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 31: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031
Table 33: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 34: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031
Table 35: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 36: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Topical Antibiotics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Topical Antibiotics Market Revenue (US$ Mn), by Drug Class, 2022
Figure 03: Global Topical Antibiotics Market Value Share, by Drug Class, 2022
Figure 04: Global Topical Antibiotics Market Revenue (US$ Mn), by Dosage Form, 2022
Figure 05: Global Topical Antibiotics Market Value Share, by Dosage Form, 2022
Figure 06: Global Topical Antibiotics Market Revenue (US$ Mn), By Indication, 2022
Figure 07: Global Topical Antibiotics Market Value Share, By Indication, 2022
Figure 08: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
Figure 09: Global Topical Antibiotics Market Value Share, by Product Type, 2022
Figure 10: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
Figure 11: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
Figure 12: Global Topical Antibiotics Market Value Share, by Region, 2022
Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2017–2031
Figure 14: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 15: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
Figure 16: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 17: Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
Figure 18: Global Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 19: Global Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
Figure 20: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
Figure 21: Global Topical Antibiotics Market Value Share, by Product Type, 2022
Figure 22: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
Figure 23: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
Figure 24: Global Topical Antibiotics Market Value Share Analysis, by Region, 2022–2031
Figure 25: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2023-2031
Figure 26: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 27: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2023–2031
Figure 28: North America Topical Antibiotics Market Value Share Analysis, by Country, 2022–2031
Figure 29: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 30: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 31: North America Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 32: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031
Figure 33: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 34: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031
Figure 35: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031
Figure 36: North America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031
Figure 37: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 38: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 39: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 40: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 41: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 42: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 43: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 44: Europe Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 45: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031
Figure 46: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 47: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031
Figure 48: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031
Figure 49: Europe Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031
Figure 50: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 51: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 52: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 53: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 55: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 56: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 57: Asia Pacific Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 58: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031
Figure 59: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 60: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031
Figure 61: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031
Figure 62: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031
Figure 63: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 64: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 65: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 66: Latin America Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 67: Latin America Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 68: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 69: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 70: Latin America Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 71: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031
Figure 72: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 73: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031
Figure 74: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031
Figure 75: Latin America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031
Figure 76: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 77: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 78: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 79: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 80: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 81: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031
Figure 82: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031
Figure 83: Middle East & Africa Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031
Figure 84: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031
Figure 85: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 86: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031
Figure 87: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031
Figure 88: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031
Figure 89: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 90: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Topical Antibiotics Market
